Related Experiment Video
Updated: May 22, 2025
Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
Published on: October 16, 2013
Utility of the ESPGHAN Biopsy-Sparing Guidelines for Celiac Disease in Children
Yojana Sunkoj1, Saurabh Talathi
1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Oklahoma Children's Hospital, University of Oklahoma Health Science Center - College of Medicine, Oklahoma City, Oklahoma, USA .
Insights
The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) biopsy-sparing approach is reliable for diagnosing celiac disease (CD). High tissue transglutaminase immunoglobulin A levels accurately identify CD, supporting its clinical application.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Gastroenterology
Background:
- Celiac disease (CD) diagnosis traditionally involves invasive duodenal biopsies.
- The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) proposed a biopsy-sparing approach.
- Evaluating the efficacy of this less invasive method is crucial for clinical practice.
Purpose of the Study:
- To assess the applicability and reliability of the ESPGHAN's biopsy-sparing diagnostic criteria for celiac disease.
- To determine the diagnostic accuracy of tissue transglutaminase immunoglobulin A (tTG-IgA) levels in identifying celiac disease.
- To evaluate the prevalence of celiac disease within the study population.
Main Methods:
- Retrospective review of patient records including celiac serologies and duodenal biopsies.
- Calculation of sensitivity and specificity for tTG-IgA at various cutoff values.
- Assessment of positive and negative predictive values for diagnosing celiac disease.
Main Results:
- The prevalence of celiac disease was found to be 9%.
- A tTG-IgA level exceeding 10 times the upper limit of normal demonstrated high specificity and predictive values.
- The ESPGHAN criteria proved effective in diagnosing celiac disease at the studied institution.
Conclusions:
- The ESPGHAN's biopsy-sparing approach is a reliable method for diagnosing celiac disease in pediatric patients.
- High tTG-IgA levels are a strong indicator for celiac disease diagnosis, potentially reducing the need for biopsies.
- Further research is recommended to validate this approach in diverse populations, particularly in the United States.
Objective:
The aim of this study was to determine the applicability of European society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN's) biopsy-sparing approach in diagnosis of celiac disease (CD).
Methods:
Charts of patients who had celiac serologies and duodenal biopsies were reviewed. Sensitivity and specificity for diagnosis of CD at different cutoffs for tissue transglutaminase immunoglobulin A were assessed.
Results:
Prevalence of CD was 9%. Tissue transglutaminase immunoglobulin A >10× upper level of normal has a high specificity, positive predictive value, and negative predictive value for diagnosis of CD.
Conclusions:
This study demonstrates that the criteria of ESPGHAN are reliable in diagnosing CD at our institution. Further studies are needed to determine the utility of this approach in the United States.
More Related Videos
Related Concept Videos
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:29Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
01:30Serum Laboratory Studies, Stool Test, Breath Test